mito99Mito-99-0103, Initially developed by Mito BioPharm LLC, Now, its global hhest R&D status is Preclinical, Therapeutic Areas: Endocrinology and Metabolic Disease, Active Indication:mito99 mito99 > Kepercayaan Pelanggan: Slot dengan Akun Aman Mito99